Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 17.8312.958.485.937.80

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 17.83 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202517.83
Mar202412.95
Mar20238.48
Mar20225.93
Mar20217.80

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 17.83
37.68
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93
-23.97
Mar2021 7.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,290.8 Cr -3.9% 5.3% 59.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,735.0 Cr -0.6% 10.3% 4.5% Stock Analytics
DIVIS LABORATORIES ₹180,312.0 Cr 1.4% 11% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,369.0 Cr -1.5% 3.3% 37.6% Stock Analytics
CIPLA ₹107,205.0 Cr -2.6% 7.9% -13.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,592.0 Cr -3.2% 2.7% 10.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.9%

5.3%

59.3%

SENSEX

-4.3%

-2.6%

-7.6%


You may also like the below Video Courses